Related Experiment Videos
Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during
S A Laucella1, E L Segura, A Riarte
1Instituto Nacional de Parasitología 'Dr Mario Fatala Chabén', Administración Nacional de Institutos de Salud 'Dr Carlos G. Malbrán, Buenos Aires, Argentina. susana@inscha.gov.ar
Insights
Soluble adhesion molecules, soluble P-selectin and soluble VCAM-1, are elevated in children with indeterminate Chagas
Area of Science:
- Immunology
- Parasitology
- Molecular Biology
Background:
- The immune response in Trypanosoma cruzi infection involves both protective and pathogenic mechanisms.
- Cell adhesion molecules (CAMs) regulate key immune processes, including host defense and immune-mediated damage.
- Soluble forms of CAMs (sCAMs) can serve as biomarkers for immune system activation.
Purpose of the Study:
- To investigate the levels of soluble P-selectin (sP-selectin) and soluble VCAM-1 (sVCAM-1) in children with indeterminate Chagas' disease.
- To assess the impact of benznidazole therapy on sP-selectin and sVCAM-1 levels.
- To determine if these soluble adhesion molecules can indicate effective parasitologic clearance.
Main Methods:
- Sera from 41 children with indeterminate Chagas' disease were analyzed for sP-selectin and sVCAM-1 levels.
- Levels were quantified before and after treatment with benznidazole or placebo.
- Correlations between sP-selectin and sVCAM-1 levels were examined.
Main Results:
- Elevated levels of sP-selectin and sVCAM-1 were observed in children with indeterminate Chagas' disease before treatment.
- A positive correlation was found between sP-selectin and sVCAM-1 levels.
- Benznidazole therapy led to a significant decrease in sP-selectin and sVCAM-1 levels compared to placebo.
Conclusions:
- Soluble adhesion molecules sP-selectin and sVCAM-1 reflect immune system activation in indeterminate Chagas' disease.
- The early reduction of these molecules post-treatment suggests their potential as indicators of successful parasitologic clearance.
Abstract:
The immune response against Trypanosoma cruzi infection has been associated with both protection and pathogenesis. Central events in host defence system- and immune-mediated damage are tightly regulated by cell adhesion molecules (CAM). Levels of sP-selectin and sVCAM-1 were measured in sera from 41 children with the indeterminate phase of Chagas' disease. Simultaneously, levels of soluble adhesion molecule were also quantified in Chagas' disease children undergoing specific chemotherapy with benznidazole. Levels of sP-selectin and sVCAM-1 were found to be elevated in children with indeterminate Chagas' disease before aetiologic therapy was started. However, a small group of patients showed sP-selectin and sVCAM-1 levels comparable to those of non-infected children. A positive correlation between levels of sVCAM-1 and sP-selectin in sera from Chagas' disease patients was found. There was a significantly greater decrease in the titres of sP-selectin and sVCAM-1 in those children receiving benznidazole therapy compared with those children receiving placebo. Measurement of soluble adhesion molecules revealed differences in the activation of the immune system in children with the indeterminate form of Chagas' disease. The early decrease of sP-selectin and sVCAM-1 levels after anti-parasitic treatment suggests that these molecules might be valuable indicators of effective parasitologic clearance.